DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Companies / Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals, Inc.
Stage unknownSan Diego, CABiotechnology
Facts
- Year of incorporation
- unknown
- Revenue range (Form D)
- Decline to Disclosesec.gov
- Rounds on record
- 1
- Disclosed raised
- unknownsum of rounds with a disclosed amount only
- Named investors
- 1
Financing history
1 rounds
- Mar 1, 2024Form D equity offering · $350M (form d sold) · 36 investorsFact SEC EDGAR Form D data sets (quarterly) · “Crinetics Pharmaceuticals, Inc. filed Form D: $350,000,028 sold of $350,000,028, Biotechnology”
Investors on record
1 edges
- Foresite Capital portfolio listing Fact foresitecapital.com
People
6 officers, 7 directors
- Dana Vivaldi Pizzuti Executive Officer sec.gov
- James Vivaldi Hassard Executive Officer sec.gov
- Jeff Vivaldi Knight Executive Officer sec.gov
- Marc Scott Wilson Executive Officer sec.gov
- Richard Scott Struthers, Phd Executive Officer/Director sec.gov
- Stephen Vivaldi Betz Executive Officer sec.gov
- Wendell Scott Wierenga, Phd Director Fact
- Caren Scott Deardorf Director Fact
- Stephanie Scott Okey Director Fact
- Rogerio Vivaldi Coelho, M.D. Director Fact
- Weston Scott Nichols, Phd Director Fact
- Camille Scott Bedrosian, M.D. Director Fact
- Matthew Scott Fust Director Fact
Timeline
1
- Mar 11, 2024Crinetics Pharmaceuticals, Inc. filed Form D: $350,000,028 sold of $350,000,028, BiotechnologyForm D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
16 observations
Every observation on this company
- Entity type: Corporation Mar 11, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Form D industry group: Biotechnology Mar 11, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Amendment: false Mar 11, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Revenue range (Form D): Decline to Disclose Mar 11, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Incorporated: overFiveYears Mar 11, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Jurisdiction: DELAWARE Mar 11, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Amount sold (Form D): $350M Mar 11, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Offering amount (Form D): $350M Mar 11, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Exemptions: 06b Mar 11, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- First sale: 2024-03-01 Mar 11, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Investors (Form D): 36 Mar 11, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Minimum investment (Form D): 0 Mar 11, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Securities offered: equity Mar 11, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Office address: 6055 LUSK BOULEVARD, SAN DIEGO, CA, 92121 Mar 11, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Listed on portfolio page: Foresite Capital Sep 16, 2026 Fact Venture organization websites (about, team, portfolio, thesis, news pages)
- Listed on portfolio page: Foresite Capital Sep 14, 2026 Fact Venture organization websites (about, team, portfolio, thesis, news pages)